HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

HER2 gene-protein assay (GPA) is a new method for the simultaneous evaluation of HER2 immunohistochemistry (IHC) and HER2 dual in situ hybridization (DISH) on single tissue sections of breast cancer. We investigated the presence of HER2 gene and protein discrepancy and HER2-heterogeneity using HER2-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Sasagu, Padilla, Mary, Kurosumi, Masafumi, Matsumoto, Hiroshi, Inoue, Kenichi, Horiguchi, Jun, Takeyoshi, Izumi, Oyama, Tetsunari, Ranger-Moore, Jim, Allred, D. Craig, Dennis, Eslie, Nitta, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937084/
https://www.ncbi.nlm.nih.gov/pubmed/27318853
http://dx.doi.org/10.1007/s10549-016-3856-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937084/
https://www.ncbi.nlm.nih.gov/pubmed/27318853
http://dx.doi.org/10.1007/s10549-016-3856-2

Ejemplares similares